The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of atezolizumab and bevacizumab in patients with advanced, progressive neuroendocrine tumors (NETs).
 
Daniel M. Halperin
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Advanced Accelerator Applications; Advanced Accelerator Applications; Advanced Accelerator Applications; Advanced Accelerator Applications; Ipsen; Ipsen; Ipsen; Ipsen; Lexicon; Lexicon; Lexicon; Lexicon; Novartis; Novartis; Novartis; Novartis
Research Funding - Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Tarveda Therapeutics (Inst); Tarveda Therapeutics (Inst); Tarveda Therapeutics (Inst); Tarveda Therapeutics (Inst); Thermo Fisher Scientific (Inst); Thermo Fisher Scientific (Inst); Thermo Fisher Scientific (Inst); Thermo Fisher Scientific (Inst)
 
Suyu Liu
No Relationships to Disclose
 
Arvind Dasari
Consulting or Advisory Role - Abbvie/Stemcentrx; Abbvie/Stemcentrx; Abbvie/Stemcentrx; Abbvie/Stemcentrx; Ipsen; Ipsen; Ipsen; Ipsen; Lexicon; Lexicon; Lexicon; Lexicon; Novartis; Novartis; Novartis; Novartis; Voluntis; Voluntis; Voluntis; Voluntis
Research Funding - eFFECTOR Therapeutics; eFFECTOR Therapeutics; eFFECTOR Therapeutics; eFFECTOR Therapeutics; Eisai; Eisai; Eisai; Eisai; Guardant Health; Guardant Health; Guardant Health; Guardant Health; Hutchison MediPharma; Hutchison MediPharma; Hutchison MediPharma; Hutchison MediPharma; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis
 
David R. Fogelman
Stock and Other Ownership Interests - GTx; GTx; GTx; GTx
Consulting or Advisory Role - Incyte; Incyte; Incyte; Incyte
 
Priya Bhosale
No Relationships to Disclose
 
Armeen Mahvash
No Relationships to Disclose
 
Shannon Dervin
Employment - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
 
Jeannelyn Estrella
No Relationships to Disclose
 
Patricia Cortazar
Employment - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
Stock and Other Ownership Interests - Genentech; Genentech; Genentech; Genentech
Honoraria - Genentech; Genentech; Genentech; Genentech
 
Dipen M. Maru
No Relationships to Disclose
 
Edward Francis Mckenna
Employment - Genentech; Genentech; Genentech; Genentech
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Asuragen; Asuragen; Asuragen; Asuragen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; Guardant Health; Guardant Health; Guardant Health; HTG Molecular Diagnostics; HTG Molecular Diagnostics; HTG Molecular Diagnostics; HTG Molecular Diagnostics; Pfizer; Pfizer; Pfizer; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche
Research Funding - 4D Molecular Therapeutics (Inst); 4D Molecular Therapeutics (Inst); 4D Molecular Therapeutics (Inst); 4D Molecular Therapeutics (Inst); Adaptimmune (Inst); Adaptimmune (Inst); Adaptimmune (Inst); Adaptimmune (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Guardant Health (Inst); Guardant Health (Inst); Guardant Health (Inst); Guardant Health (Inst); HTG Molecular Diagnostics (Inst); HTG Molecular Diagnostics (Inst); HTG Molecular Diagnostics (Inst); HTG Molecular Diagnostics (Inst); Karus Therapeutics (Inst); Karus Therapeutics (Inst); Karus Therapeutics (Inst); Karus Therapeutics (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); OncoPlex Diagnostics (Inst); OncoPlex Diagnostics (Inst); OncoPlex Diagnostics (Inst); OncoPlex Diagnostics (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Silicon Biosytems (Inst); Silicon Biosytems (Inst); Silicon Biosytems (Inst); Silicon Biosytems (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; Guardant Health; Guardant Health; Guardant Health; HTG Molecular Diagnostics; HTG Molecular Diagnostics; HTG Molecular Diagnostics; HTG Molecular Diagnostics; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Pfizer; Pfizer; Pfizer; Pfizer
 
Katja Schulze
Employment - Genentech; Genentech; Genentech; Genentech
Stock and Other Ownership Interests - Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
 
Phillip Andrew Futreal
Consulting or Advisory Role - GenePlus; GenePlus; GenePlus; GenePlus
 
Walter C. Darbonne
Employment - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche
 
Cindy Yun
Employment - Genentech; Genentech; Genentech; Genentech
 
Patrick Hwu
Stock and Other Ownership Interests - Dragonfly Therapeutics; Dragonfly Therapeutics; Dragonfly Therapeutics; Dragonfly Therapeutics; Immatics; Immatics; Immatics; Immatics
Consulting or Advisory Role - Dragonfly Therapeutics; Dragonfly Therapeutics; Dragonfly Therapeutics; Dragonfly Therapeutics; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Immatics; Immatics; Immatics; Immatics; Sanofi; Sanofi; Sanofi; Sanofi
Research Funding - Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst)
 
James C. Yao
Consulting or Advisory Role - Crinetics Pharmaceuticals; Crinetics Pharmaceuticals; Crinetics Pharmaceuticals; Crinetics Pharmaceuticals; Ipsen; Ipsen; Ipsen; Ipsen; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis; Novartis; Novartis; Novartis; Tarveda Therapeutics; Tarveda Therapeutics; Tarveda Therapeutics; Tarveda Therapeutics